Variable clinical features of patients with Fabry disease and outcome of enzyme replacement therapy

被引：0
|
作者：
Dutra-Clarke, Marina [1 ]
Tapia, Daisy [2 ]
Curtin, Emily [2 ]
Ruenger, Dennis [1 ]
Lakatos, Anita [2 ]
Alandy-Dy, Zyza [2 ]
Freedkin, Linda [2 ]
Hall, Kathy [2 ]
Ercelen, Nesrin [2 ]
Alandy-Dy, Jousef [2 ]
Knight, Margaret [2 ]
Pahl, Madeline [2 ]
Lombardo, Dawn [2 ]
Kimonis, Virginia [2 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Univ Calif Irvine, Orange, CA 92668 USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2021年 / 132卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2020.12.069
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
63
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [41] PREDICTORS OF LONG-TERM OUTCOME IN A SPANISH COHORT OF PATIENTS WITH FABRY DISEASE ON ENZYME REPLACEMENT THERAPY
    Goicoechea, Marian
    Gomez-Preciado, Francisco
    Benito, Silvia
    Torras, Joan
    Torra, Roser
    Huerta, Ana
    Restrepo, Alejandra
    Ugalde, Jessica
    Astudillo, Daniela
    Agraz, Irene
    Lopez-Mendoza, Manuel
    De Arriba, Gabriel
    Corchete, Elena
    Quiroga, Borja
    Luisa Martin-Conde, Maria
    Jose Gutierrez, Maria
    Lopes, Vanessa
    Ramos, Carmela
    Mendez, Irene
    Cao, Mercedes
    Dominguez, Fernando
    Ortiz, Alberto
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 363 - 363
  • [42] Clinical benefit in patients with Morbus Fabry under enzyme replacement therapy
    Breunig, F
    Knoll, A
    Weidemann, F
    Beer, M
    Strotmann, J
    Wanner, C
    [J]. MEDIZINISCHE KLINIK, 2006, 101 (04) : A97 - A97
  • [43] Looking for predictors of mortality in patients with Fabry disease on enzyme replacement therapy
    Reisin, Ricardo
    Ferrari, Gustavo
    Kisinovsky, Isaac
    Neumann, Pablo
    Caceres, Guillermo
    Azcurra, Zulema
    Gastaldi, Anibal
    Palombo, Marina
    Choua, Martin
    Forrester, Mariano
    Cedrolla, Martin
    Antongiovanni, Norberto
    Fernandez, Segundo
    Dupuy, S.
    Amartino, Hernan M.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2016, 117 (02) : S99 - S100
  • [44] Renal function in patients with fabry disease on enzyme replacement therapy (ERT)
    West, Michael
    Cybulla, Markus
    Feriozzi, Sandro
    Schwarting, Andreas
    Schiffmann, Raphael
    Mehta, Atul
    Sunder-Plassmann, Gere
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 13 - 13
  • [45] Enzyme replacement therapy administered during hemodialysis in patients with Fabry disease
    Kosch, M
    Koch, HG
    Oliveira, JP
    Soares, C
    Bianco, F
    Breuning, F
    Rasmussen, Å
    Schaefer, RM
    [J]. KIDNEY INTERNATIONAL, 2004, 66 (03) : 1279 - 1282
  • [46] IMPACT OF SWITCHING ENZYME REPLACEMENT THERAPY ON PATIENTS AFFECTED BY FABRY DISEASE
    Jovanovic, A.
    Sharma, R.
    Kempshall, S.
    Thompson, L.
    Bleakley, C.
    Bell, L.
    Taylor, R.
    Whitby, J.
    Smith, E.
    Meehan, M.
    Hill, A.
    Hendriksz, C. J.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 : S146 - S146
  • [47] Long Term Treatment with Enzyme Replacement Therapy in Patients with Fabry Disease
    Oder, Daniel
    Nordbeck, Peter
    Wanner, Christoph
    [J]. NEPHRON, 2016, 134 (01) : 30 - 36
  • [48] Effect of Enzyme Replacement Therapy on Diastolic Function in Patients With Fabry Disease
    Kim, Minjeong
    Seo, Jiwon
    Cho, Iksung
    Ha, Jong-Won
    Shim, Chi Young Y.
    Hong, Geu-Ru
    [J]. CIRCULATION, 2023, 148
  • [49] EFFECT OF ENZYME REPLACEMENT THERAPY ON ENDOTHELIAL FUNCTION IN PATIENTS WITH FABRY DISEASE
    Cokan, Andreja
    Rainer, Sasa
    Vujkovac, Bojan
    Verovnik, Franc
    Benko, Davorin
    Sabovic, Miso
    [J]. NEPHROLOGY, 2005, 10 : A227 - A228
  • [50] ENZYME REPLACEMENT THERAPY STABILIZES QUALITY OF LIFE IN PATIENTS WITH FABRY DISEASE
    Kantola, I.
    Hietaharju, A.
    Taurio, J.
    Kananen, K.
    Peschek, T.
    Tarusalo, T.
    Kantola, T.
    Viikari, J.
    [J]. CLINICAL THERAPEUTICS, 2009, 31 : S42 - S42
12345